Clinical Trial Update: Allogeneic UCB-derived CAR-T for SLE [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating an allogeneic umbilical cord blood-derived CAR-T therapy for systemic lupus erythematosus is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Allogeneic UCB-derived CAR-T (CAR-T cell therapy (umbilical cord blood-derived))

Snippet

Sponsor: Chengdu Ucello Biotechnology Co., Ltd. | Conditions: SLE - Systemic Lupus Erythematosus | EARLY_Phase 1 | Status: RECRUITING